| 000 | 01825 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515163015.0 | ||
| 264 | 0 | _c20090409 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a0385-5600 | ||
| 024 | 7 |
_a10.1111/j.1348-0421.2008.00097.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIshii, Koji | |
| 245 | 0 | 0 |
_aNeutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model. _h[electronic resource] |
| 260 |
_bMicrobiology and immunology _cFeb 2009 |
||
| 300 |
_a75-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Viral _ximmunology |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aChemokine CCL2 _xanalysis |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aInterleukin-6 _xanalysis |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aSevere acute respiratory syndrome-related coronavirus _ximmunology |
| 650 | 0 | 4 |
_aSevere Acute Respiratory Syndrome _ximmunology |
| 650 | 0 | 4 | _aSpike Glycoprotein, Coronavirus |
| 650 | 0 | 4 | _aVaccines, Inactivated |
| 650 | 0 | 4 |
_aViral Envelope Proteins _ximmunology |
| 650 | 0 | 4 |
_aViral Vaccines _ximmunology |
| 650 | 0 | 4 | _aVirus Replication |
| 700 | 1 | _aHasegawa, Hideki | |
| 700 | 1 | _aNagata, Noriyo | |
| 700 | 1 | _aAmi, Yasushi | |
| 700 | 1 | _aFukushi, Shuetsu | |
| 700 | 1 | _aTaguchi, Fumihiro | |
| 700 | 1 | _aTsunetsugu-Yokota, Yasuko | |
| 773 | 0 |
_tMicrobiology and immunology _gvol. 53 _gno. 2 _gp. 75-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1348-0421.2008.00097.x _zAvailable from publisher's website |
| 999 |
_c18729855 _d18729855 |
||